2022
DOI: 10.1186/s12905-022-01842-7
|View full text |Cite
|
Sign up to set email alerts
|

Factors associated with uptake of contraceptives among HIV positive women on dolutegravir based anti-retroviral treatment-a cross sectional survey in urban Uganda

Abstract: Background In May 2018, following the preliminary results of a study in Botswana that reported congenital anomalies in babies born to HIV-positive women taking dolutegravir drug, the WHO issued a teratogenicity alert. However, there are scarce data on the impact of this guidance on contraceptive uptake among women taking dolutegravir. We assessed the uptake of contraceptives in HIV-positive women of reproductive age on dolutegravir regimens. Methods … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 15 publications
0
1
0
Order By: Relevance
“… 15 , 16 However, the uptake is higher than 38.4% reported in urban Uganda. 17 This discrepancy may be attributed to differences in sample size and geographic settings.…”
Section: Discussionmentioning
confidence: 99%
“… 15 , 16 However, the uptake is higher than 38.4% reported in urban Uganda. 17 This discrepancy may be attributed to differences in sample size and geographic settings.…”
Section: Discussionmentioning
confidence: 99%